Results 171 to 180 of about 710,416 (277)

Reframing Patient-Centered Medical Education. [PDF]

Neurol Educ
Strowd RE.
europepmc   +1 more source

Design of Solar Energy Harvesting Reactor From 2D to 3D Structures for Solar Thermal Conversion

Carbon Innovation, EarlyView.
ABSTRACT Solar energy utilisation is pivotal for advancing sustainable and renewable energy solutions, yet the rational design of high‐efficiency photothermal conversion devices remains a critical challenge. This paper systematically examines the evolution of photothermal reactor architectures from two‐dimensional (2D) to 3D structures, emphasising ...
Haozhe Zhuang, Runsen Wang, Yuxuan Meng, Yuejun Chen, Sanli Tang, Yuefei Ruan, Vellaisamy A. L. Roy, Meng Lin, Xianguang Meng   +8 more
wiley   +1 more source

Heart failure-induced reprogramming of salt-evoked neurovascular coupling in the rat hypothalamus. [PDF]

J Physiol
Roy RK, Lira EC, Ongolo MB, Filosa JA, Stern JE.   +4 more
europepmc   +1 more source

Increased Insulin Action, Glucose Metabolism and Muscle Function in Supervillin‐Knockout and Supervillin‐Mutant Mice

Cytoskeleton, EarlyView.
ABSTRACT We here describe mouse models with complementary homozygous Svil mutations. In skeletal muscle, Svil‐Mut mice express the Svil‐encoded N‐terminus fused to the βgal‐neo gene‐trap tag and lack the highly conserved archvillin C‐terminus; Svil‐KO mice lack expression of all known Svil‐encoded proteins; and Svil‐LoxP mice contain loxP sites for ...
Tara C. Smith, Lauren A. Tauer, Randall H. Friedline, Xiaodi Hu, Duy Tran, Yangyi E. Luo, Nacima Hadjout‐Rabi, Elisabeth R. Barton, Jason K. Kim, Elizabeth J. Luna   +9 more
wiley   +1 more source

Clinical Utility of Serum CA 19-9 Level in Colorectal Carcinoma Patients With Normal Serum Carcinoembryonic Antigen Levels: Correlation With Clinicopathological Features and Survival Outcomes. [PDF]

Cureus
Mallick A, Roy A, Roy R.
europepmc   +1 more source

Model‐based clinical pharmacology profiling of subcutaneous nivolumab in renal cell carcinoma: Bridging to alternative dosing regimens and indications

Clinical Pharmacology &Therapeutics, EarlyView.
A novel model‐informed drug development (MIDD) approach was employed to derive the coprimary endpoints (time‐averaged serum concentration over 28 days [Cavgd28] and minimum serum concentration at steady state [Cminss]) of the phase III CheckMate 67T study (NCT04810078).
Yue Zhao, Zheyi Hu, Elizabeth Gibson, Li Zhu, Heather Vezina, Anna G. Kondic   +5 more
wiley   +1 more source

How Institutional Environments Shape the ESG–Growth Relation: Evidence From Europe

Corporate Social Responsibility and Environmental Management, EarlyView.
ABSTRACT As global financial markets increasingly integrate non‐financial criteria, companies are reinforcing the strategic role of sustainability and its impact on market value, although this cannot overlook how different institutional structures shape investor perceptions.
Laura Bango‐López, Cristina Gutiérrez‐López, Paula Castro, María Belén Lozano‐García   +3 more
wiley   +1 more source

The Price of Circularity: Exploring the Determinants of Consumer Willingness to Pay

Corporate Social Responsibility and Environmental Management, EarlyView.
ABSTRACT The transition towards a circular economy (CE) requires not only technological and organisational innovation but also consumer engagement in adopting circular products. A key driver of this process is consumers' stated willingness to pay (WTP) a premium, which remains constrained by psychological, perceptual and contextual barriers.
Valerio Muto, Vincenzo Basile, Nunzia Petacca, Anna Prisco   +3 more
wiley   +1 more source

A Fokker-Planck framework for control of epidemics. [PDF]

J Math Biol
Parkinson C, Roy S.
europepmc   +1 more source

The Synergy of Green HRM and a Proactive Environmental Strategy in Cultivating Environmental and Financial Performance Through Green Innovation

Corporate Social Responsibility and Environmental Management, EarlyView.
ABSTRACT This study examines how green human resource management (HRM) contributes to environmental and financial performance via green innovation. We develop and test a moderated mediation model in which green product and green process innovation act as parallel mediating mechanisms, while proactive environmental strategy moderates their effectiveness.
Ana Labella‐Fernández, Thomas Van Waeyenberg, Carlos Martínez‐Egea   +2 more
wiley   +1 more source